DHR Meet the Memo Series: Antelope Surgical Solutions

​Join us for a better kind of deal flow in our Meet the Memo Series: with Dr. Amy Wu, MD, FACS – Founder & CEO of Antelope Surgical Solutions – where founders pitch, operators share insights, and funders discover the next big thing in biotech.

​About the Meet the Memo series:

​ We’re bringing together Founders, Operators, and Early Stage Investors in biotech and health/medtech to spark meaningful connections and real collaboration. Each session gives you a chance to hear from the minds behind game-changing companies—and this time, we're excited to feature Dr. Amy Wu, a board-certified head and neck surgeon and surgical innovation trailblazer.

​Dr. Wu is the Founder & CEO of Antelope Surgical Solutions, a biotech startup developing the world’s first multimodal radioligand fluorescent drug platform for cancer surgery. With FDA IND clearance on their lead asset, Antelope is changing the game for real-time cancer visualization, surgical precision, and patient outcomes.

​Whether you're here to share knowledge, find your next investment, or meet potential partners—this is the room you want to be in. Join us to hear Dr. Wu’s journey, learn from her experience, and connect with others shaping the future of biotech.

​Who Should Attend:

​ ​Active Investors in Series A/B

​​CVCs, GPs, LPs with a biotech thesis

​​Research Hospitals and Pharma Strategic Partners ​ ​

​What to Expect:

​​Founder will pitch for 20 minutes about their product and results . RSVP accepted attendees can then ask questions or explore further with team for 20 minutes .

​RSVP guests will receive company deck, investment memo and investment platform post event